Aclaris Therapeutics, Inc. is a specialty pharmaceutical company focused on the development of a topically applied therapy directed toward the removal of seborrheic keratosis (SK) and other verrucoid lesions of the skin.

from http://www.aclaristx.com/

Patents show all

3Issued1Applications

Clinical Trials show all

7Phase 23Phase 31Phase 1/Phase 2

SEC Filings show all

8-K2410-Q6D510-K2S-11